http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0620885-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8f70c5b59b293a0220e30a752bb017f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2006-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98b55cd43db2bd969adbbf14fc8c5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d08f1812f4d495661d732722d284830
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0828d6851c41354f214314061b4106
publicationDate 2011-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0620885-A2
titleOfInvention imidazo [1,2-a] pyridin-3-yl acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof
abstract IMIDAZO [1,2-a] PYRIDIN-3-IL-ACETIC ACID HYDRAZIDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL USES OF THE SAME. The present invention relates to novel imidazo [1,2-a] pyridin-3-yl acetic acid hydrazides of formula (I) wherein R 1, R 2 and R 3 have different meanings, and pharmaceutically acceptable salts, polymorphs, hydrates, tautomers, solvates and stereoisomers thereof. Compounds of formula (1) are useful for treating or preventing, in a human or nonhuman mammal, diseases associated with GABA-Aβ receptor modulation, anxiety, epilepsy, sleep disorders, including insomnia, and for inducing hypnosis by sedation, anesthesia, sleep and muscle relaxation. The invention also provides synthetic processes for preparing said compounds.
priorityDate 2006-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431662630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426751698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23581873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23581872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411298166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20389367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67152069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23582850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11636795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23581876
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23582849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409755967
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454209771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524544
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413569488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413569484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID409082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423146754
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14143688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413569485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67152089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422154767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423146758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420933449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15965566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420933444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419706542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969472
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16214888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415782976
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15348
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67152070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016

Total number of triples: 84.